Association of prostatic inflammation with down-regulation of macrophage inhibitory cytokine-1 gene in symptomatic benign prostatic hyperplasia

Journal of Urology

Volumn 171, Issue 6 I, 2004, Pages 2330-2335

  Taoka, Rikiya ^a   Tsukuda, Fumio ^a   Ishikawa, Masashi ^a   Haba, Reiji ^a   Kakehi, Yoshiyuki ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Gene expression; Prostate; Prostatic hyperplasia; Prostatitis

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYSTECTOMY; DISEASE CLASSIFICATION; DNA MICROARRAY; DOWN REGULATION; GENE; GENE CONTROL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE INHIBITORY CYTOKINE 1 GENE; MALE; PRIORITY JOURNAL; PROSTATE ADENOMA; PROSTATE HYPERTROPHY; PROSTATITIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STROMA; TRANSURETHRAL RESECTION;

EID: 2442608523     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000127760.87421.e9     Document Type: Article

References (20)

1. Prakash, K., Pirozzi, G., Elashoff, M., Munger, W., Waga, I., Dhir, R. et al: Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays. Proc Natl Acad Sci USA, 99: 7598, 2002
2. Kakehi, Y., Segawa, T., Wu, X.-X., Kulkarni, P., Dhir, R. and Getzenberg, R. H.: Down-regulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia. Prostate, 59: 351, 2004
3. Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y. et al: MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA, 94: 11514, 1997
4. Strelau, J., Bottner, M., Lingor, P., Suter-Crazzolara, C., Galter, D., Jaszai, J. et al: GDF-15/MIC-1 a novel member of the TGF-beta superfamily. J Neural Transm Suppl, 60: 273, 2000
5. Paralkar, V. M., Vail, A. L., Grasser, W. A., Brown, T. A., Xu, H., Vukicevic, S. et al: Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. J Biol Chem, 273: 13760, 1998
6. Hromas, R., Hufford, M., Sutton, J., Xu, D., Li, Y. and Lu, L.: PLAB, a novel placental bone morphogenetic protein. Biochem Biophys Acta, 1354: 40, 1997
7. Lawton, L. N., Bonaldo, M. F., Jelene, P. C., Qiu, L., Baumes, S. A., Marcelin, R. A. et al: Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. Gene, 203: 17, 1997
8. Nakamura, T., Scorilas, A., Stephan, C., Yousef, G. M., Kristiansen, G., Jung, K. et al: Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues. Br J Cancer, 88: 1101, 2003
9. McNeal, J. E.: Origin and evolution of benign prostatic enlargement. Invest Urol, 15: 340, 1978
10. Chute, C. G., Panser, L. A., Girman, C. J., Oesterling, J. E., Guess, H. A., Jacobsen, S. J. et al: The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol, 150: 85, 1993
11. Homma, Y., Kawabe, K., Tsukamoto, T., Yamanaka, H., Okada, K., Okajima, E. et al: Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score. Int J Urol, 4: 40, 1997
12. Kaplan, S. A., Te, A. E., Pressler, L. B. and Olsson, C. A.: Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. J Urol, 154: 1764, 1995
13. Nickel, J. C., Downey, J., Young, I. and Boag, A.: Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int, 84: 976, 1999
14. Nickel, J. C., True, L. D., Krieger, J. N., Berger, R. E., Boag, A. H. and Young, I. D.: Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int, 87: 797, 2001
15. Krieger, J. N., Nyberg, L., Jr. and Nickel, J. C.: NIH consensus definition and classification of prostatitis. JAMA, 282: 236, 1999
16. Theyer, G., Kramer, G., Assmann, I., Sherwood, E., Preinfalk, W., Marberger, M. et al: Phenotypic characterization of infiltrating leucocytes in benign prostatic hyperplasia. Lab Invest, 66: 96, 1992
17. Kohnen, P. W. and Drach, G. W.: Pattern of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol, 121: 755, 1979
18. Anim, J. T., Udo, C. and John, B.: Characterisation of inflammatory cells in benign prostatic hyperplasia. Acta Histochem, 100: 439, 1998
19. Cunha, G. R., Chung, L. W., Shannon, J. M., Taguchi, O. and Fujii, H.: Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions. Recent Prog Horm Res, 39: 559, 1983
20. Yan, G., Fukabori, Y., Nikolaropoulos, S., Wang, F. and McKeehan, W. L.: Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. Mol Endocrinol, 6: 2123, 1992